Ozempic pancreatitis risk — the boxed-adjacent warning, symptoms (severe abdominal pain radiating to back, vomiting), what to do, and who should avoid GLP-1s.
Short answer: Acute pancreatitis is a labeled warning for Ozempic — rare but serious. Stop the drug and seek urgent care if you develop severe persistent abdominal pain (often radiating to the back, possibly with vomiting). Prior pancreatitis is a reason for caution, and Ozempic isn't recommended in those patients.
The warning signs
- Severe, persistent abdominal pain
- Pain radiating through to the back
- Vomiting that doesn't stop
- Fever with abdominal pain
Who's at higher risk
History of pancreatitis, gallstones, high triglycerides, heavy alcohol use. If any apply, the prescriber weighs risk — Ozempic is often avoided in prior pancreatitis.
What trials showed
SUSTAIN trials recorded pancreatitis at low rates (~0.1–0.3%), similar to other diabetes therapies — a real but uncommon risk the label takes seriously.
Rare — ~0.1–0.3% in trials, comparable to other diabetes drugs, but serious enough for a labeled warning.
Generally no — prior pancreatitis on a GLP-1 is a reason to avoid the class.
FDA label — warnings and precautions; SUSTAIN safety analysis.